A groundbreaking review by researchers at Central South University highlights six critical signaling pathways—CCNE1/CDK2, MYC/CDK9, CDK4/CDK6/FOXM1, PTEN/PI3K/AKT/mTOR, AURKB, and VEGFA/VEGFR—as ...

Breakthroughs in a rare cancer treatment are helping a New York woman conquer an aggressive bone tumor. Doctors at Cohen ...

Yet to be published data from clinical study combining OST-HER2 with palliative radiation in dogs with unresected, primary osteosarcoma shows clinical and radiographic arrest of the primary tumor ...

Dr. Darrell Green, Lead Author of UEA's Norwich Medical School The search for kinder, more targeted treatments for osteosarcoma is an important area of focus for Children with Cancer UK.

While genetic sequencing has previously helped to uncover different subtypes of other cancers, like breast or skin cancer, for which those patients then receive targeted treatment personalised to ...

In a landmark study published in Current Molecular Pharmacology, a team led by Dr. Zhen Zhang from Central South University has identified six pivotal ...

In parallel, we believe the data from these two studies support the use of OST-HER2 in all phases of canine osteosarcoma treatment and we are hopeful to obtain conditional approval with our newly ...

OS Therapies Announces Positive Data for OST-HER2 in the Treatment of Unresected Osteosarcoma in Dogs Opening the Potential for Use as Front-Line Therapy in Humans Yet to be published data from ...